ArticleJornal vascular brasileiro2025
Splenorenal bypass in suprarenal aneurysm with solitary left kidney: a case report.
Article in Jornal vascular brasileiro, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal revascularization in patients with a solitary functioning kidney and a suprarenal abdominal aortic aneurysm (AAA) is a surgical challenge due to the risk of renal ischemia and postoperative renal dysfunction. We present a unique case in which a 69-year-old male with a solitary left kidney and suprarenal AAA was managed successfully with a preemptive splenic artery-to-left renal artery transposition (splenorenal bypass) followed by aneurysmorrhaphy. This approach preserved renal function and avoided ischemic insult during aortic reconstruction. At 2 years of follow-up, the patient maintains stable renal parameters and the reconstruction is patent, underscoring the utility of splenorenal bypass as a viable alternative in anatomically constrained and high-risk scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.